Production of transgenic calves expressing an shRNA targeting myostatin
Open Access
- 2 December 2011
- journal article
- Published by Wiley in Molecular Reproduction and Development
- Vol. 79 (3), 176-185
- https://doi.org/10.1002/mrd.22007
Abstract
Myostatin (MSTN) is a well‐known negative regulator of muscle growth. Animals that possess mutations within this gene display an enhanced muscling phenotype, a desirable agricultural trait. Increased neonatal morbidity is common, however, resulting from complications arising from the birth of offspring with increased fetal muscle mass. The objective of the current research was to generate an attenuated MSTN‐null phenotype in a large‐animal model using RNA interference to enhance muscle development without the detrimental consequences of an inactivating mutation. To this end, we identified a series of short interfering RNAs that demonstrated effective suppression of MSTN mRNA and protein levels. To produce transgenic offspring capable of stable MSTN suppression in vivo, a recombinant lentiviral vector expressing a short hairpin RNA (shRNA) targeting MSTN for silencing was introduced into bovine fetal fibroblasts. These cells were used as nucleus donors for somatic cell nuclear transfer (SCNT). Twenty blastocysts were transferred into seven recipient cows resulting in five pregnancies. One transgenic calf developed to term, but died following delivery by Caesarean‐section. As an alternative strategy, microinjection of recombinant lentiviral particles into the perivitelline space of in vitro‐produced bovine zygotes was utilized to produce 40 transgenic blastocysts that were transferred into 14 recipient cows, resulting in 7 pregnancies. Five transgenic calves were produced, of which three expressed the transgene. This is the first report of transgenic livestock produced by direct injection of a recombinant lentivirus, and expressing transgenes encoding shRNAs targeting an endogenous gene (myostatin) for silencing. Mol. Reprod. Dev. 79: 176–185, 2012.Keywords
Funding Information
- National Institutes of Health-National Institute for Child Health and Human Development (1R21HD055631-01A2, 5R01HD058969-02)
- USDA National Institute of Food and Agriculture-National Research Initiative Competitive Grant (2007-35205-17921)
- Biotechnology Risk Assessment Competitive Grant (2009-33120-20238)
This publication has 39 references indexed in Scilit:
- Generation of Cloned Transgenic Cats Expressing Red Fluorescence Protein1Biology of Reproduction, 2008
- Lentiviral Transduction of Mammary Stem Cells for Analysis of Gene Function during Development and CancerCell Stem Cell, 2008
- A Mutation in the Myostatin Gene Increases Muscle Mass and Enhances Racing Performance in Heterozygote DogsPLoS Genetics, 2007
- A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheepNature Genetics, 2006
- Cloning of short hairpin RNAs for gene knockdown in mammalian cellsNature Methods, 2004
- Generation of Transgenic Cattle by Lentiviral Gene Transfer into Oocytes1Biology of Reproduction, 2004
- Powerful Genes — Myostatin Regulation of Human Muscle MassThe New England Journal of Medicine, 2004
- Myostatin Mutation Associated with Gross Muscle Hypertrophy in a ChildThe New England Journal of Medicine, 2004
- Efficient transgenesis in farm animals by lentiviral vectorsEMBO Reports, 2003
- A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattleNature Genetics, 1997